Federal Circuit Rules For Shwarz Pharma In Suit Over Univasc Patent
The U.S. District Court for the District of New Jersey had found that Teva's product, Moexipril HCl Tablets,would not infringe U.S. Patent No. 4,743,450, asserted by Schwarz Pharma as licensee of Warner Lambert. However, the Court of Appeals has remanded the case to the District Court for further proceedings, Teva said.
To view the full article, register now.